{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:34:31Z","timestamp":1790285671082,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016319","name":"China National Biotec Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.vaccine.2025.127891","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T02:21:50Z","timestamp":1761618110000},"page":"127891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immunogenicity and safety of co-administration of sabin-strain-based inactivated poliovirus vaccine, diphtheria-tetanus-acellular pertussis vaccine, and live attenuated hepatitis A vaccine in 18-month-old children: A multicenter randomized controlled non-inferiority trial in China"],"prefix":"10.1016","volume":"67","author":[{"given":"Xiaoyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruize","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanwen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127891_bb0005","series-title":"Vaccines Against Malaria: Hope in a Gathering Storm. National Academies Press (US)","author":"Institute of Medicine (US) Committee on Malaria Vaccines","year":"1996"},{"issue":"10500","key":"10.1016\/j.vaccine.2025.127891_bb0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(25)01037-2","article-title":"Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the global burden of disease study 2023","volume":"406","year":"2025","journal-title":"Lancet (London, England)"},{"issue":"40","key":"10.1016\/j.vaccine.2025.127891_bb0015","first-page":"429","article-title":"Hepatitis A vaccines: WHO position paper, October 2022","volume":"97","author":"World Health Organization","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127891_bb0020","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.vaccine.2018.01.043","article-title":"The impact of expanded program on immunization with live attenuated and inactivated hepatitis A vaccines in China, 2004-2016","volume":"36","author":"Sun","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127891_bb0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2188\/jea.JE20130022","article-title":"Development, production, and postmarketing surveillance of hepatitis A vaccines in China","volume":"24","author":"Cui","year":"2014","journal-title":"J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.127891_bb0030","author":"Global Polio Eradication Initiative"},{"issue":"35","key":"10.1016\/j.vaccine.2025.127891_bb0035","doi-asserted-by":"crossref","first-page":"934","DOI":"10.15585\/mmwr.mm6535a3","article-title":"Cessation of trivalent Oral poliovirus vaccine and introduction of inactivated poliovirus vaccine - worldwide, 2016","volume":"65","author":"Hampton, L. M., Farrell, M., Ramirez-Gonzalez, A., Menning, L., Shendale, S., Lewis, I., Rubin, J., Garon, J., Harris, J., Hyde, T., Wassilak, S., Patel, M., Nandy, R., Chang-Blanc, D., & Immunization Systems Management Group of the Global Polio Eradication Initiative","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"17","key":"10.1016\/j.vaccine.2025.127891_bb0040","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.vaccine.2021.02.073","article-title":"Immunogenicity and safety of Sabin-strain based inactivated poliovirus vaccine replacing salk-strain based inactivated poliovirus vaccine: an innovative application of different strain-IPVs replacement","volume":"39","author":"Chen","year":"2021","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2025.127891_bb0045","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.46234\/ccdcw2021.270","article-title":"Childhood immunization schedule for National Immunization Program Vaccines - China (version 2021)","volume":"3","author":"National Health Commission Of The People's Republic Of China","year":"2021","journal-title":"China CDC weekly"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127891_bb0050","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2195786","article-title":"Vaccine co-administration in adults: an effective way to improve vaccination coverage","volume":"19","author":"Bonanni","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127891_bb0055","volume":"No. 102","author":"Administration","year":"2019","journal-title":"Guiding principles for grading adverse reactions in clinical trials of preventive vaccines"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127891_bb0060","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.vaccine.2015.01.072","article-title":"Comparing vaccines: a systematic review of the use of the non-inferiority margin in vaccine trials","volume":"33","author":"Donken","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127891_bb0065","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/vaccines10030472","article-title":"Immunogenicity and safety of childhood combination vaccines: A systematic review and Meta-analysis","volume":"10","author":"Liu","year":"2022","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127891_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-008215","article-title":"Safety of routine childhood vaccine coadministration versus separate vaccination","volume":"7","author":"Bauwens","year":"2022","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2025.127891_bb0075","first-page":"9","article-title":"Immunogenicity and safety of concomitant administration of the Sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in China","volume":"137","author":"Xu","year":"2023","journal-title":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases"},{"key":"10.1016\/j.vaccine.2025.127891_bb0080","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127891_bb0085","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3390\/vaccines11081336","article-title":"The decay of pertussis antibodies in children aged 0-14 years in Jiangsu Province","volume":"11","author":"Wang","year":"2023","journal-title":"China Vaccines"},{"key":"10.1016\/j.vaccine.2025.127891_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1618883","article-title":"Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies","volume":"16","author":"Sheng","year":"2025","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127891_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/vaccines12020123","article-title":"Immune persistence following primary immunization and the immunogenicity and safety of a booster dose of a multidose Sabin strain-based inactivated polio vaccine in infants aged 18 months","volume":"12","author":"Feng","year":"2024","journal-title":"Vaccines"},{"issue":"50","key":"10.1016\/j.vaccine.2025.127891_bb0100","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1016\/j.vaccine.2011.09.131","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127891_bb0105","first-page":"1456","article-title":"Evaluation of the immunogenicity and safety of lyophilized live attenuated hepatitis A vaccine in children aged 18\u201324 months","volume":"34","author":"Dong","year":"2021","journal-title":"Chinese Journal of Biologicals"},{"issue":"21","key":"10.1016\/j.vaccine.2025.127891_bb0110","article-title":"Safety and 6-month immune persistence of inactivated poliovirus vaccine (Sabin strains) simultaneously administrated with other vaccines for primary and booster immunization in Jiangxi Province","volume":"42","author":"Guo","year":"2024","journal-title":"China Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127891_bb0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jiac.2019.11.012","article-title":"Immunogenicity and safety of a DTaP-IPV\/Hib pentavalent vaccine given as primary and booster vaccinations in healthy infants and toddlers in Japan","volume":"26","author":"Nakayama","year":"2020","journal-title":"Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy"},{"key":"10.1016\/j.vaccine.2025.127891_bb0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12887-015-0525-2","article-title":"The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule","volume":"15","author":"Rusmil","year":"2015","journal-title":"BMC Pediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127891_bb0125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40121-022-00724-7","article-title":"Post-marketing safety surveillance of a childhood pentavalent diphtheria-tetanus-acellular pertussis-polio and Haemophilus influenzae type B (DTaP-IPV\/\/Hib) vaccine in South Korea","volume":"12","author":"Yang","year":"2023","journal-title":"Infect Dis Ther"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127891_bb0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0264-410X(94)00017-H","article-title":"Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines","volume":"13","author":"Mark","year":"1995","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127891_bb0135","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1045-1870(03)00033-5","article-title":"Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines","volume":"14","author":"Rennels","year":"2003","journal-title":"Semin Pediatr Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25011880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25011880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:54:05Z","timestamp":1763607245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25011880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":27,"alternative-id":["S0264410X25011880"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127891","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of co-administration of sabin-strain-based inactivated poliovirus vaccine, diphtheria-tetanus-acellular pertussis vaccine, and live attenuated hepatitis A vaccine in 18-month-old children: A multicenter randomized controlled non-inferiority trial in China","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127891"}}